LEAP test box beside a test tube containing a blood sample, labeled 'LEAP' and 'Lung Enzyme Activity Protocol'.

Protecting Those Who Served

Veterans are twice as likely to be diagnosed with lung cancer and often don’t qualify for standard screening. LEAP is a simple, accessible blood test that helps detect lung cancer early—before symptoms appear, and when it’s most treatable—offering peace of mind and a chance at earlier, more effective care.

LEAP for the Early Detection of Lung Cancer

LEAP (Lung Enzyme Activity Profile) detects specific enzyme activity in your blood. Abnormal patterns may be linked to early-stage lung cancer—even before symptoms appear. Results are clear, fast, and help guide next steps.

The LEAP blood test detects specific enzyme patterns linked to lung cancer through a simple blood test.

Enzyme icon.

An Abnormal result indicates that additional testing, like a chest CT, may be recommended by your healthcare provider.

Magnifying glass icon.

Veterans Face Higher Risk But Are
Often Left Out of Screening Programs

  • Lung cancer is 2X more common

    among veterans than the general population.¹

  • Only 2.7% of eligible veterans

    receive lung cancer screening, compared to 83% for colorectal cancer.²

  • Toxic exposures and tobacco use

    affect millions of veterans, but many don’t meet standard screening criteria.³

Clear Results for Clear Steps Forward

LEAP delivers straightforward results designed to support timely next steps.

A normal result provides peace of mind with continued annual testing, while an abnormal result prompts your provider to recommend follow-up care or imaging—helping you act early when it matters most.

Flowchart explaining blood test results: normal results lead to peace of mind with annual follow-up, abnormal results lead to standard care with confirmatory procedures.

Fast, Accessible Testing

  • Standard blood draw (in-clinic or on-site)

  • No need for advanced imaging or hospital visits

  • Results in just a few days

  • Mobile phlebotomy options available

  • Partnering with healthcare organizations and philanthropic funders

Why Consider LEAP?

LEAP supports early detection efforts by identifying molecular signals in your blood—potentially before lung cancer would show up on a scan.

LEAP is clinically validated
with 99.8% negative predictive value

  • Checkmark icon.

    Simple

    Requires only a standard blood draw

  • Checkmark icon.

    Safe

    No radiation, no imaging, no prep

  • Checkmark icon.

    Fast

    Receive results in just a few days

  • Checkmark icon.

    Proactive

    May trigger earlier follow-up care

  • Checkmark icon.

    Trusted

    Backed by clinical research and performed in a CLIA-certified lab

How to Get the LEAP Test

  • Large number one icon.

    Talk to your healthcare provider

    Your doctor can help determine if LEAP is appropriate for you. Contact Ease Healthcare for a listing of providers.

  • Large number two icon.

    Complete your blood draw

    Testing is done either in your provider’s office or through a participating Ease Healthcare partner.

  • Large number three icon.

    Review your results

    You’ll receive your results within a few days, and your doctor will explain what they mean and recommend next steps if needed.

More Information About LEAP

Is the LEAP test covered by insurance?

Most health insurance plans do not currently cover the cost of the LEAP test. However, you may be able to use pre-tax dollars from a Flexible Spending Account (FSA) or Health Savings Account (HSA). Check with your plan administrator or insurance provider to confirm eligibility.

Is LEAP FDA-approved?

No. LEAP is a laboratory-developed test (LDT) that has not been cleared or approved by the FDA. It is performed by a CLIA-certified and CAP-accredited lab authorized to conduct high-complexity clinical testing.

Can LEAP give false results?

Yes. Like all medical tests, LEAP may produce false-positive or false-negative results.

  • A false-positive result means the test indicates a possible issue when no cancer is present.

  • A false-negative result means the test may miss the presence of cancer.

Test results should always be interpreted by a healthcare provider in the context of your medical history and current symptoms.


¹Maurice NM, Tanner NT. Lung Cancer Screening at the VA: Past, Present and Future. Seminars in Oncology, 2022
²Implementation of Lung Cancer Screening in the Veterans Health Administration. CHEST, 2022; 161(1):181–190.
³SEER (Surveillance, Epidemiology, and End Results) Program. Cancer Stat Facts: Lung and Bronchus Cancer.

LEAP RESOURCES

RELATED NEWS & UPDATES